Update on immunopathogenesis and immunotherapy in multiple sclerosis by Selter RC, Hemmer B

Get full text

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta by Castrop F, Haslinger B, Hemmer B, Buck D

Get full text

MRI plaque imaging reveals high-risk carotid plaques especially in diabetic patients irrespective of the degree of stenosis by Holzer K, Liebig T, Winkler C, Feurer R, Sepp D, Pelisek Jaroslav, Bockelbrink Angelina, Heider P, Saam T, Esposito L, Pauly O, Sadikovic S, Hemmer B, Poppert H

Get full text

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. by Sawcer, S, Hellenthal, G, Pirinen, M, Spencer, C, Patsopoulos, N, Moutsianas, L, Dilthey, A, Su, Z, Freeman, C, Hunt, SE, Edkins, S, Gray, E, Booth, DR, Potter, S, Goris, A, Band, G, Oturai, AB, Strange, A, Saarela, J, Bellenguez, C, Fontaine, B, Gillman, M, Hemmer, B, Gwilliam, R, Zipp, F

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. by Beecham, A, Patsopoulos, N, Xifara, D, Davis, M, Kemppinen, A, Cotsapas, C, Shah, T, Spencer, C, Booth, D, Goris, A, Oturai, A, Saarela, J, Fontaine, B, Hemmer, B, Martin, C, Zipp, F, D'Alfonso, S, Martinelli-Boneschi, F, Taylor, B, Harbo, H, Kockum, I, Hillert, J, Olsson, T, Ban, M, Oksenberg, JR